论文部分内容阅读
目的探讨稳心颗粒联合辛伐他汀治疗冠心病心律失常的临床效果。方法 78例冠心病心律失常患者,随机分为对照组和观察组,各39例。对照组患者采用辛伐他汀治疗,观察组患者在对照组基础上配合服用稳心颗粒治疗,对比两组患者的治疗效果。结果观察组治疗后,甘油三酯(TG)、总胆固醇(TC)和低密度脂蛋白胆固醇(LDL-C)水平均明显低于对照组(P<0.05);观察组总有效率明显高于对照组(P<0.05)。结论稳心颗粒联合辛伐他汀治疗冠心病心律失常效果显著,安全性高,值得广泛应用于临床。
Objective To investigate the clinical effect of Wenxinkeli combined with simvastatin on arrhythmia of coronary heart disease. Methods A total of 78 patients with coronary heart disease and arrhythmia were randomly divided into control group and observation group, with 39 cases in each group. The patients in the control group were treated with simvastatin. The patients in the observation group were treated with Wenxin Granule on the basis of the control group, and the treatment effect was compared between the two groups. Results The levels of triglyceride (TG), total cholesterol (TC) and low density lipoprotein cholesterol (LDL-C) in observation group were significantly lower than those in control group after treatment (P <0.05). The total effective rate in observation group was significantly higher than that in control group Control group (P <0.05). Conclusion Wenxin granule combined with simvastatin is effective in treating arrhythmia of coronary heart disease, which is safe and should be widely used in clinic.